Open-label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures.

Rectally administered LEV combined with a standard treatment protocol provided good control of seizure activity in patients with CS. The validity of these results should be confirmed in a double-blinded, placebo-controlled clinical trial.